Creating Tomorrow's Vaccines Today - www. novavax. com
Clic: 219, Página web añadida: Oct 14, 2012
|
|
| |||||||
Novavax, Inc. (Nasdaq: NVAX) is a clinical-stage biopharmaceutical company creating novel vaccines to address a broad range of infectious diseases worldwide, including H1N1, using advanced proprietary virus-like particle (VLP) technology. The company